Prudential Financial’s Relay Therapeutics RLAY Stock Holding History

Prudential Financial’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Buy	32,020 +10,670	+50%	+$155K	﹤0.01%	1837
2026 Q1	$212K	Buy	+21,350	New	+$191K	﹤0.01%	2121
2025 Q4	–	Sell	-14,825	Closed	-$77.4K	–	2404
2025 Q3	$77.4K	Sell	14,825 -343,400	-96%	-$1.31M	﹤0.01%	2297
2025 Q2	$1.24M	Sell	358,225 -35,150	-9%	-$105K	﹤0.01%	1580
2025 Q1	$1.03M	Sell	393,375 -156,270	-28%	-$612K	﹤0.01%	1555
2024 Q4	$2.26M	Buy	549,645 +173,000	+46%	+$941K	﹤0.01%	1242
2024 Q3	$2.67M	Sell	376,645 -73,700	-16%	-$551K	﹤0.01%	1317
2024 Q2	$2.94M	Buy	450,345 +87,895	+24%	+$601K	﹤0.01%	1190
2024 Q1	$3.01M	Buy	+362,450	New	+$3.54M	﹤0.01%	1212
2020 Q4	–	Sell	-5,210	Closed	-$222K	–	2495
2020 Q3	$222K	Buy	+5,210	New	+$199K	﹤0.01%	2264

Other funds holding RLAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Prudential Financial's RLAY Position: Q2 2026 in Review

Prudential Financial increased its Relay Therapeutics (RLAY) stake by 50% in Q2 2026, buying an estimated $155K and bringing the position to 32,020 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #1837.

Prudential Financial first reported a position in RLAY in Q3 2020 and has held it in 10 quarters since. The position peaked at $3.01M in Q1 2024. 166 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

Prudential Financial held 32,020 shares of Relay Therapeutics worth $599K as of Q2 2026.
Prudential Financial bought 10,670 Relay Therapeutics shares in Q2 2026, an estimated $155K.
Relay Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1837 holding.
Prudential Financial first reported a position in Relay Therapeutics in Q3 2020 and has held it in 10 quarters since.
Prudential Financial's Relay Therapeutics position peaked at $3.01M in Q1 2024.
166 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.